Urokinase-induced mitogenesis is mediated by casein kinase 2 and nucleolin

Current Biology

Volumn 9, Issue 24, 1999, Pages 1468-1476

  Dumler, Inna ^a   Stepanova, V ^a,b   Jerke, U ^a   Mayboroda, O A ^c   Vogel, F ^a   Bouvet, P ^d   Tkachuk, V ^b   Haller, H ^e   Gulba, D C ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d UPR 9006   (France)

^e HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033576631     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(00)80116-5     Document Type: Article

References (52)

1. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809.
2. Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW: Platelet-derived growth factor promotes smooth muscle cell migration and intimai thickening in a rat model of balloon angioplasty. J Clin Invest 1992, 89:507-511.
3. Nabel EG, Yang ZY, Plautz G, Forough R, Zhan X, Haudenschild CC, et al.: Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature 1993, 362:844-846.
4. Pickering JG, Bacha PA, Weir L, Jekanowski J, Nichols JC, Isner JM: Prevention of smooth muscle cell outgrowth from human atherosclerotic plaque by a recombinant cytotoxin specific for epidermal growth factor receptor. J Clin Invest 1993, 91:724-729.
5. Blasi F: upa, uPAR, PAI-1 : Key intersection of proteolytic, adhesive and hemotactic highways? Immunol Today 1997, 18:415-417.
6. Chapman H: Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr Opin Cell Biol 1997, 9:714-724.
7. Kirchheimer JC, Wojta J, Christ G, Binder B: Proliferation of a human epidermal tumor cell line stimulated by urokinase. FASEB J 1987, 1:125-128.
8. He CJ, Rebibou JM, Peraldi MN, Meulders Q, Rondeau E: Growth factor-like effect of urokinase type plasminogen activator in human renal cells. Biochem Biophys Res Comm 1991, 176:1408-1416.
9. Rabbani S, Mazar AP, Bernier SM, Haq M, Bolivar I, Henkin J, Golzman D: Structural requirements for the growth factor activity of the aminoterminal domain of urokinase. J Biol Chem 1992, 267:14151-14156.
10. Kanse SM, Benzakour O, Kanthou C, Kost C, Lijnen HR, Preissner KT: Induction of vascular SMC proliferation by urokinase indicates a novel mechanism of action in vasoproliferative disorders. Arterioscler Thromb Vasc Biol 1997, 17:2848-2854.
11. Herbert JM, Lamarche I, Carmelit P: Urokinase and tissue-type plasminogen activator are required for the mitogenic and chemotactic effects of bovine fibroblast growth factor and platelet-derived growth factor-BB for vascular smooth muscle cells. J Biol Chem 1997, 272:23585-23591.
12. De Petro G, Copeta A, Barlati S: Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts. Exp Cell Res 1994, 213:286-294.
13. Fischer K, Lutz V, Wilhelm O, Schmitt M, Graeff H, Heiss P, et al.: Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function. FEBS Lett 1998, 438:101-105.
14. Koopman JL, Slomp J, De Bart ACW, Quax PHA, Verheijen JH: Mitogenic effects of urokinase on melanoma cells are independent of high affinity binding to the urokinase receptor. J Biol Chem 1998, 273:33267-33272.
15. Busso N, Masur SK, Lazeda D, Waxman S, Ossowski L: Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. J Cell Biol 1994, 128:259-270.
16. Dumler I, Petri T, Schleuning WD: Induction of c-fos gene expression by urokinase-type plasminogen activator in human ovarian cancer cells. FEBS Lett 1994, 343:103-106.
17. Bohuslav J, Horejsi V, Hansmann C, Stöckl J, Weidle UH, Majdic O, et al: Urokinase plasminogen activator receptor, β2-integrins, and Src-kinases within a single receptor complex of human monocytes. J Exp Med 1995, 181:1381-1390.
18. Resnati M, Guttinger M, Valcamonica S, Sidenius N, Blasi F, Fazioli F: Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO J 1996, 15:1572-1582.
19. Fazioli F, Resnati M, Sidenius N, Higashimoto Y, Appella E, Blasi F: A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity. EMBO J 1997, 16:7279-7286.
20. Rabbani SA, Gladu J, Mazar AP, Henkin J, Golzman D: Induction in human osteoblastic cells (SaOs2) of the early response genes fos, jun, and myc by the amino-terminal fragment (ATF) of urokinase. J Cell Physiol 1997, 172:137-145.
21. Nguyen DHD, Hussaini IM, Gonias SL: Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility. J Biol Chem 1998, 273:8502-8507.
22. Tang H, Kerins DM, Hao Q, Inagami T, Vaughan DE: The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells. J Biol Chem 1998, 273:18268-18272.
23. Dumler I, Weis A, Mayboroda OA, Maasch C, Jerke U, Haller H, Gulba DC: The Jak/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells. J Biol Chem 1998, 273:315-321.
24. Koshelnick Y, Ehart M, Hufnagl P, Heinrich PC, Binder BR: Urokinase receptor is associated with the components of the JAK1/STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumour cell line TCL-598. J Biol Chem 1997, 272:28563-28567.
25. Dumler I, Kopmann A, Weis A, Mayboroda OA, Wagner K, Gulba DC, Haller H: Urokinase activates the Jak/Stat signal transduction pathway in human vascular endothelial cells. Arterioscl Thromb Vasc Biol 1999, 19:290-297.
26. Srivastava M, Fleming PJ, Pollard HB, Burns AL: Cloning and sequencing of the human nucleolin cDNA. FEBS Lett 1989, 250:99-105.
27. Ginisty H, Sicard H, Roger B, Bouvet P: Structure and function of nucleolin. J Cell Sci 1999, 112:761-772.
28. Li D, Dobrowolska G, Krebs EG: The physical association of casein kinase 2 with nucleolin. J Biol Chem 1996, 271:15662-15668.
29. Ghisolfi L, Kharrat A, Joseph G, Amalric F, Erard M: Concerted activities of the RNA recognition and the glycine-rich C-terminal domains of nucleolin are required for efficient complex formation with pre-ribosomal RNA. Bur J Biochem 1992, 209:541-548.
30. Kiledjian M, Dreyfuss G: Primary structure and binding activity of the hnRNP U protein: Binding RNA through RGG box. EMBO J 1992, 11:2655-2664.
31. Cobianchi F, Karpel RL, Williams KR, Notario V, Wilson SH: Mammalian heterogeneous nuclear ribonucleoprotein complex protein A1. Large-scale overproduction in Escherichia coli and cooperative binding to single-stranded nucleic acids. J Biol Chem 1988, 263:1063-1071.
32. Bouvet P, Diaz JJ, KIndbeiter K, Madjar JJ, Amalric F: Nucleolin interacts with several ribosomal proteins through its RGG domain. J Biol Chem 1998, 273:19025-19029.
33. Litchfield DW, Lüscher B: Casein kinase II in signal transduction and cell cycle regulation. Mol Cell Biochem 1993, 127/128:187-199.
34. Allende JE, Allende CC: Protein kinase CK2: an enzyme with multiple substrates and a puzzling regulation. FASEB J 1995, 9:313-323.
35. Guerra B, Boldyreff B, Sarno S, Cesaro L, Issinger OG, Pinna LA: CK2: a protein kinase in need of control. Pharmacol Ther 1999, 82:303-313.
36. Seger D, Gechtman Z, Shaltiel S: Phosphorylation of vitronectin by casein kinase II. Identification of the sites and their promotion of cell adhesion and spreading. J Biol Chem 1998, 273:24805-24813.
37. Bonnet H, Filhol O, Truchet I, Brethenou P, Cochet C, Amalric F, Bouche G: Fibroblast growth factor-2 binds to the regulatory β subunit of CK2 and directly stimulates CK2 activity toward nucleolin. J Biol Chem 1996, 271:24781-24787.
38. Borer RA, Lehner C, Eppenberger HM, Nigg EA: Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 1989, 56:379-390.
39. Semenkovich CF, Ostlund Jr RE, Olson MO, Yang JW: A protein partially expressed on the surface of Hep G2 cells that binds lipoproteins specifically is nucleolin. Biochemistry 1990, 29:9708-9713.
40. Kibbey MC, Johnson B, Petryshyn R, Jucker M, Kleinman HK: A 110-kD nuclear shuttling protein, nucleolin, binds to the neurite-promoting IKVAV site of laminin-1. J Neurosci Res 1995, 42:314-322.
41. Deng JS, Ballou B, Hofmeister JK: Internalization of anti-nucleolin antibody into viable Hep-2 cells. Mol Biol Rep 1996, 23:191-195.
42. De Verdugo UR, Selinka HC, Huber M, Kramer, Kellermann J, Hofschneider PH, Kandolf R: Characterization of a 100-kilodalton binding protein for the siy serotypes of coxsackie B viruses. J Virol 1995, 69:6751-6757.
43. + cells. J Biol Chem 1998, 273:21988-21997.
44. Yu D, Schwartz MZ, Petryshyn R: Effect of laminin on the nuclear localization of nucleolin in rat intestinal epithelial IEC-6 cells. Biochem Biophys Res Commun 1998, 247:186-192.
45. Larrucea S, González-Rubio C, Cambronero R, Ballou B, Bonay P, López-Granados E, et al.: Cellular adhesion mediated by factor J, a complement inhibitor. Evidence for nucleolin involvement. J Biol Chem 1998, 273:31718-31725.
46. Hanakahi LA, Dempsey LA, Li MJ, Maizels N: Nucleolin is one component of the B cell-specific transcription factor and switch region binding protein, LR1. Proc Natl Acad Sci USA 1997, 94:3605-3610.
47. Dumler I, Petri T, Schleuning WD: Interaction of urokinase-type plasminogen activator (u-PA) with its cellular receptor (u-PAR) induces phosphorylation on tyrosine of a 38 kDa protein. FEBS Lett 1993, 322:37-40.
48. Otto A, Thiede B, Müller EC, Scheler C, Wittmann-Liebold B, Jungblut P: Identification of human myocardial proteins separated by two-dimensional electrophoresis using an effective sample preparation for mass spectrometry. Electrophoresis 1996, 17:1643-1650.
49. Wilm MS, Mann M: Electrospray and taylor-cone theory, dole's beam of macromolecules at least? Int J Mass Spectro Ion Process 1994, 136:167-180.
50. Wilm M, Schevchenko A, Houthaeve T, Breit S, Schweigerer L, Fotsis T, Mann M: Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature 1996, 379:466-469.
51. Haller H, Lindschau C, Quass P, Distler A, Luft FC: Differentiation of vascular smooth muscle cells and the regulation of protein kinase C-α Circ Res 1995, 76:21-29.
52. Haller H, Bauer E, Quass P, Behrend M, Lindschau C, Distler A, Luft FC: High glucose concentrations and protein kinase C isoforms in vascular smooth muscle cells. Kidney Int 1996, 47:1057-1067.